SECFiling News & Analysis
4 articles
Market Mood
LADR Reports Asset Management Head Sells 35,000 Shares
On May 29 and June 2, 2026, Robert Perelman, Head of Asset Management at Ladder Capital Corp (LADR), sold 35,000 shares of Common Stock at an average price of $10.25. This sale accounted for 7.55% of his direct holdings, reducing them from 463,684 to 428,684 shares. This transaction is noted as Perelman's largest individual direct sale in the past two years. Perelman remains a significant shareholder, maintaining a material ownership position that aligns with shareholder interests.
Read More
UroGen Pharma (URGN) CMO Sells 5,222 Shares for $143,000
Mark Schoenberg, CMO of UroGen Pharma Ltd. (URGN), sold 5,222 shares for approximately $143,000, as reported in a SEC Form 4 filing. Following the transaction, his direct ownership consists of 139,763 shares valued at about $3.81 million. This sale represents a 25.81% decrease in Schoenberg's direct holdings over the past year, where he has completed seven sell transactions. The shares were sold at a weighted average price of $27.30 amid a 168.23% one-year total return as of June 12, 2026.
Read More
CLOA Position Increases by 63,417 Shares Valued at $3.3M
Inspirion Wealth Advisors increased its position in the iShares AAA CLO Active ETF (CLOA) by 63,417 shares, equating to an estimated value of $3.3 million, according to a recent SEC filing dated April 8, 2026. Following this transaction, CLOA now comprises 3.64% of Inspirion's reportable assets. As of April 7, 2026, CLOA shares reported a 6.3% increase over the past year, despite trailing the S&P 500 by 31 percentage points. The fund's objective is to provide capital preservation and current income with a 5.2% dividend yield, targeting income-seeking investors.
Read More
London Co Sells $51M Stake in Armstrong World Industries Shares
On February 17, 2026, London Co of Virginia disclosed the sale of 269,356 shares of Armstrong World Industries (NYSE:AWI) for an estimated $51.40 million. This sale, recorded in an SEC filing, reduced their stake to 2.06% of the fund’s reportable assets. The sale contributed to a quarter-end value decline of $61.96 million for Armstrong's position amid the company reporting full-year revenue of $1.6 billion, a 12% increase from the previous year. Armstrong's shares were valued at $163.86, reflecting a 16% gain over the past year, slightly outpacing the S&P 500's 15% gain.
Read More